Sarfaraz K Niazi

US Patent:

6365198, Apr 2, 2002

Filed:

Jan 28, 2001

Appl. No.:

09/681147

Inventors:

Sarfaraz K. Niazi - Deerfield IL

Assignee:

Gulf Pharmaceutical Industries

International Classification:

A01K 6500

US Classification:

424725

Abstract:

A pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids in humans and animals and a method of preparation for this composition are provided here. The preferred composition consists of an alcoholic extract of Huangqin, Huanglian, Huangbo, Opuntia and Pheretima dissolved in vegetable oil from where alcohol is essentially removed by evaporation. The composition is then packaged in a soft gelatin capsule for oral administration or mixed with wax to make an ointment suitable for rectal administration.

US Patent:

6419963, Jul 16, 2002

Filed:

Apr 22, 2001

Appl. No.:

09/681520

Inventors:

Sarfaraz K Niazi - Deerfield IL 60015

International Classification:

A61K 3578

US Classification:

424757, 424725, 424539, 514 26

Abstract:

Provided here is a pharmaceutical composition containing beeswax, olive oil, -sitosterol and the herb Coptis chinesis Franch for safe and quick treatment for infant and adult diaper rash. Also provided here is a methodology for the treatment of diaper rash wherein the treatment consists of compositions that contain naturally derived anti-inflammatory agents, an antimicrobial agents and such components that they provide an occlusive coating when applied to the afflicted surface.

US Patent:

6447820, Sep 10, 2002

Filed:

Jan 22, 2001

Appl. No.:

09/681137

Inventors:

Sarfaraz K Niazi - Deerfield IL 60015

International Classification:

A61K 3578

US Classification:

424767, 424400, 424502, 424725, 514946, 514947

Abstract:

The disclosed is a treatment of existing and prevention of new skin scars in humans and animals using a topical application containing alcoholic extracts of and in a specific combination.

US Patent:

6462083, Oct 8, 2002

Filed:

Nov 13, 2001

Appl. No.:

10/010316

Inventors:

Sarfaraz K. Niazi - Deerfield IL 60015

International Classification:

A61K 3120

US Classification:

514560, 514787, 514966

Abstract:

This invention provides a suppository base composition of erucic acid and beeswax with improved chemical stability, moldability, and shelf-life. The inventive suppository base also stimulates localized blood flow to the administration site.

US Patent:

6495174, Dec 17, 2002

Filed:

Feb 21, 2001

Appl. No.:

09/681204

Inventors:

Sarfaraz K. Niazi - Deerfield IL 60015

International Classification:

A61K 3578

US Classification:

424756, 424725, 424773, 424777, 424778

Abstract:

Described here a composition comprising of alcoholic extracts of herbs RHIZOMA ZINGIBERIS RECENS, RHIZOMA PINELLIAE, FLOS CARTHAMI, RADIX REHMANNIAE, RADIX ANGELICAE SINESIS, RADIX PAENOIAE RUBRA, CACUMEN BIOTAE, SEMEN SESAMI NIGRUM, RADIX POLYGONI MULTIFLORI, FRUCTUS MORI combined with TINCTURE CAPSICUM, TINCTURE CANTHARIDINATE, and OLEUM RICINI for direct application to scalp for the treatment of all kinds of alopecia in humans. Alternately, the herbs listed here can be used individually.

US Patent:

6555118, Apr 29, 2003

Filed:

Feb 22, 2001

Appl. No.:

09/681207

Inventors:

Sarfaraz K Niazi - Deerfield IL 60015

International Classification:

A61K 3578

US Classification:

424401, 424725, 424773, 424774, 424779, 424 937, 424767, 424 7806, 424DIG 13, 514783, 514844, 514944, 514945

Abstract:

A pharmaceutical preparation for the treatment of wounds and ulcers in humans and animals and a method of preparation of the same are provided here. The composition consists of an alcoholic extract of Huangqin, Huanglian, Huangbai, Opuntia, Dilong, and -sitosterol (from Soybean extract), in a vegetable oil-wax base, from where the alcohol is essentially removed by evaporation. The composition is used as a topical ointment for the treatment of wounds in its preferred embodiment. Wounds, in particular those occurring in the skin as second and third degree burns, stasis ulcers, trophic lesions, such as decubitus ulcers, diabetic ulcers, surgical wounds, severe cuts, diaper rash, cracked nipples and abrasions which are commonly resistant to the natural healing process, may be treated with this composition. The application of this combination to wounds greatly accelerates the rate of healing and reduces scarring as the mechanism of action proposed here involves regeneration of skin through stimulation of stem cells that allows healing without substantial scar formation.

US Patent:

8066947, Nov 29, 2011

Filed:

Jun 16, 2009

Appl. No.:

12/485725

Inventors:

Sarfaraz K. Niazi - Deerfield IL, US

International Classification:

A62B 7/08
B01D 59/26
B01D 53/14

US Classification:

422122, 95149, 96290

Abstract:

An air scrubber for eliminating an associated airborne contaminants and sterilizing air provided to protect against nocosomial infections, environmental allergens, weapons of biological and chemical attacks and operations requiring clean environment. The air scrubber includes a housing containing an alkali solution at pH 14 through which air passes and suspended liquid particles removed; provides are made for use in central air-conditioning systems, stand-alone applications and portable use along with respirators.

US Patent:

8183035, May 22, 2012

Filed:

Sep 7, 2011

Appl. No.:

13/227324

Inventors:

Sarfaraz Niazi - Deerfield IL, US

Assignee:

Therapeutic Proteins International, LLC - Chicago IL

International Classification:

C12M 1/12

US Classification:

4352973, 4352961

Abstract:

A method of manufacturing biological products in a single container from the growth of cells to purification of the product is performed in a flexible disposable bioreactor that uses only a compressed gas for mixing and gasification. A porous septum is used to create the gasification and mixing as well as to separate a chromatography media used to harvest and purify a biological product in the same container. The closed container can be used in any environment without the risk of contamination to the product or the risk of contamination of environment with the product. This allows large manufacturing of hazardous substances, drugs and vaccines anywhere at the lowest cost possible. Numerous applications can be found in counter-terrorism and biodefense operations as well in managing epidemic illnesses.